Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2008

01-06-2008 | Preclinical Study

Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death

Authors: Elena P. Moiseeva, Raimond Heukers

Published in: Breast Cancer Research and Treatment | Issue 3/2008

Login to get access

Abstract

Indole-3-carbinol (I3C), a dietary chemopreventive compound, induces cell death in human breast cancer cells by modulating activities of Src and epidermal growth factor receptor (EGFR). The effect of I3C on NF-κB, constitutively activated in breast cancer cells, was investigated. Nuclear extracts of MDA-MB-468, MDA-MB-231 and HBL100 cells contained all of the Rel proteins with similar expression patterns in the latter two. The level of NF-κB-regulated reporter gene expression was in the order HBL100 << MDA-MB-468 << MDA-MB-231. Upstream inhibition, using PI3K, EGFR or IKKβ inhibitors, resulted in cell-specific effects on expression of the NF-κB-regulated reporter gene and endogenous genes Bcl-xL, IκBα and IL-6, as well as on cell viability. The expression patterns of Rel and several NF-κB-regulated genes and the response to LY249002 in MDA-MB-468 cells contrasted with those in other cells. I3C induced NF-κB-regulated reporter gene expression at 12 h in MDA-MB-468 cells. Conversely, it was reduced at 24 h in HBL100 cells. I3C treatment for 6 h alone or in combination with TNFα induced NF-κB-regulated reporter gene expression, detected 5 h later, in MDA-MB-468, but not HBL100 cells. I3C induced NF-κB p65/p50 DNA binding at 6.5 h, preceded by association of IKKβ with the Src/EGFR complex and increased phospho-IκBα in MDA-MB468 cells. TNFα increased I3C-induced apoptosis in MDA-MB-468 and MDA-MB-231 cells. It also induced apoptosis, enhanced by I3C, in HBL100 cells. Hence, regulation of constitutive NF-κB was cell-specific. I3C influenced the NF-κB pathway in a cell-specific manner, which was not related to apoptosis. However, the combination of I3C and TNFα increased apoptosis in all cell lines.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
2.
go back to reference Gandini S, Merzenich H, Robertson C et al (2000) Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 36:636–646PubMedCrossRef Gandini S, Merzenich H, Robertson C et al (2000) Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 36:636–646PubMedCrossRef
3.
go back to reference Dos Santos Silva I, Mangtani P, McCormack V et al (2002) Lifelong vegetarianism and risk of breast cancer: a population-based case-control study among South Asian migrant women living in England. Int J Cancer 99:238–244PubMedCrossRef Dos Santos Silva I, Mangtani P, McCormack V et al (2002) Lifelong vegetarianism and risk of breast cancer: a population-based case-control study among South Asian migrant women living in England. Int J Cancer 99:238–244PubMedCrossRef
4.
go back to reference Hermann S, Linseisen J, Chang-Claude J (2002) Nutrition and breast cancer risk by age 50: a population-based case-control study in Germany. Nutr Cancer 44:23–34PubMedCrossRef Hermann S, Linseisen J, Chang-Claude J (2002) Nutrition and breast cancer risk by age 50: a population-based case-control study in Germany. Nutr Cancer 44:23–34PubMedCrossRef
5.
go back to reference Hirose K, Takezaki T, Hamajima N et al (2003) Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women. Int J Cancer 107:276–282PubMedCrossRef Hirose K, Takezaki T, Hamajima N et al (2003) Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women. Int J Cancer 107:276–282PubMedCrossRef
6.
go back to reference Sieri S, Krogh V, Pala V et al (2004) Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev 13:567–572PubMed Sieri S, Krogh V, Pala V et al (2004) Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev 13:567–572PubMed
7.
go back to reference Fung TT, Hu FB, Holmes MD et al (2005) Dietary patterns and the risk of postmenopausal breast cancer. Int J Cancer 116:116–121PubMedCrossRef Fung TT, Hu FB, Holmes MD et al (2005) Dietary patterns and the risk of postmenopausal breast cancer. Int J Cancer 116:116–121PubMedCrossRef
8.
go back to reference Ambrosone CB, McCann SE, Freudenheim JL et al (2004) Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr 134:1134–1138PubMed Ambrosone CB, McCann SE, Freudenheim JL et al (2004) Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr 134:1134–1138PubMed
9.
go back to reference Pathak DR, He JP, Charzewska J (2005) Joint association of high cabbage/sauerkraut intake at 12–13 years of age and adulthood with reduced breast cancer risk in Polish migrant women: results from the US component of the Polish Womens Health Study (PWHS). Cancer Epidemiol Biomarkers Prev 14:2755S–2755S Pathak DR, He JP, Charzewska J (2005) Joint association of high cabbage/sauerkraut intake at 12–13 years of age and adulthood with reduced breast cancer risk in Polish migrant women: results from the US component of the Polish Womens Health Study (PWHS). Cancer Epidemiol Biomarkers Prev 14:2755S–2755S
10.
go back to reference Malloy VL, Bradlow HL, Orentreich N (1997) Interaction between a semisynthetic diet and indole-3-carbinol on mammary tumor incidence in Balb/cfC3H mice. Anticancer Res 17:4333–4337PubMed Malloy VL, Bradlow HL, Orentreich N (1997) Interaction between a semisynthetic diet and indole-3-carbinol on mammary tumor incidence in Balb/cfC3H mice. Anticancer Res 17:4333–4337PubMed
11.
go back to reference Bradlow HL, Michnovicz J, Telang NT et al (1991) Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571–1574PubMedCrossRef Bradlow HL, Michnovicz J, Telang NT et al (1991) Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571–1574PubMedCrossRef
12.
go back to reference Rahman KM, Sarkar FH, Banerjee S et al (2006) Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol Cancer Ther 5:2747–2756PubMedCrossRef Rahman KM, Sarkar FH, Banerjee S et al (2006) Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol Cancer Ther 5:2747–2756PubMedCrossRef
13.
go back to reference Wattenberg LW, Loub WD (1978) Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 38:1410–1413PubMed Wattenberg LW, Loub WD (1978) Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 38:1410–1413PubMed
14.
go back to reference Kojima T, Tanaka T, Mori H (1994) Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54:1446–1449PubMed Kojima T, Tanaka T, Mori H (1994) Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54:1446–1449PubMed
15.
go back to reference Grubbs CJ, Steele VE, Casebolt T et al (1995) Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15:709–716PubMed Grubbs CJ, Steele VE, Casebolt T et al (1995) Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15:709–716PubMed
16.
go back to reference Bell MC, Crowley-Nowick P, Bradlow HL et al (2000) Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78:123–129PubMedCrossRef Bell MC, Crowley-Nowick P, Bradlow HL et al (2000) Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78:123–129PubMedCrossRef
17.
go back to reference Naik R, Nixon S, Lopes A et al (2006) A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia. Int J Gynecol Cancer 16:786–790PubMedCrossRef Naik R, Nixon S, Lopes A et al (2006) A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia. Int J Gynecol Cancer 16:786–790PubMedCrossRef
18.
go back to reference Rosen CA, Bryson PC (2004) Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 18:248–253PubMedCrossRef Rosen CA, Bryson PC (2004) Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 18:248–253PubMedCrossRef
19.
go back to reference Malejka-Giganti D, Parkin DR, Bennett KK et al (2007) Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination. Eur J Cancer Prev 16:130–141PubMedCrossRef Malejka-Giganti D, Parkin DR, Bennett KK et al (2007) Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination. Eur J Cancer Prev 16:130–141PubMedCrossRef
20.
go back to reference Donald S, Verschoyle RD, Greaves P et al (2004) Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma. Int J Cancer 111:961–967PubMedCrossRef Donald S, Verschoyle RD, Greaves P et al (2004) Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma. Int J Cancer 111:961–967PubMedCrossRef
21.
go back to reference Anderton MJ, Manson MM, Verschoyle RD et al (2004) Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 10:5233–5241PubMedCrossRef Anderton MJ, Manson MM, Verschoyle RD et al (2004) Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 10:5233–5241PubMedCrossRef
22.
go back to reference Reed GA, Arneson DW, Putnam WC et al (2006) Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3’-diindolylmethane. Cancer Epidemiol Biomarkers Prev 15:2477–2481PubMedCrossRef Reed GA, Arneson DW, Putnam WC et al (2006) Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3’-diindolylmethane. Cancer Epidemiol Biomarkers Prev 15:2477–2481PubMedCrossRef
23.
go back to reference Crowell JA, Page JG, Levine BS et al (2006) Indole-3-carbinol, but not its major digestive product 3,3’-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450. Toxicol Appl Pharmacol 211:115–123PubMedCrossRef Crowell JA, Page JG, Levine BS et al (2006) Indole-3-carbinol, but not its major digestive product 3,3’-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450. Toxicol Appl Pharmacol 211:115–123PubMedCrossRef
24.
go back to reference Zhang X, Malejka-Giganti D (2003) Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas. Anticancer Res 23:2473–2479PubMed Zhang X, Malejka-Giganti D (2003) Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas. Anticancer Res 23:2473–2479PubMed
25.
go back to reference Parkin DR, Malejka-Giganti D (2004) Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3’-diindolylmethane and its parent compound indole-3-carbinol. Cancer Detect Prev 28:72–79PubMedCrossRef Parkin DR, Malejka-Giganti D (2004) Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3’-diindolylmethane and its parent compound indole-3-carbinol. Cancer Detect Prev 28:72–79PubMedCrossRef
26.
go back to reference Leibelt DA, Hedstrom OR, Fischer KA et al (2003) Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3’-diindolylmethane in sprague-dawley rats. Toxicol Sci 74:10–21PubMedCrossRef Leibelt DA, Hedstrom OR, Fischer KA et al (2003) Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3’-diindolylmethane in sprague-dawley rats. Toxicol Sci 74:10–21PubMedCrossRef
27.
go back to reference Chinni SR, Sarkar FH (2002) Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 8:1228–1236PubMed Chinni SR, Sarkar FH (2002) Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 8:1228–1236PubMed
28.
go back to reference Howells LM, Gallacher-Horley B, Houghton CE et al (2002) Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line. Mol Cancer Ther 1:1161–1172PubMed Howells LM, Gallacher-Horley B, Houghton CE et al (2002) Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line. Mol Cancer Ther 1:1161–1172PubMed
29.
go back to reference Howells LM, Hudson EA, Manson MM (2005) Inhibition of phosphatidylinositol 3-kinase/protein kinase B signaling is not sufficient to account for indole-3-carbinol-induced apoptosis in some breast and prostate tumor cells. Clin Cancer Res 11:8521–8527PubMedCrossRef Howells LM, Hudson EA, Manson MM (2005) Inhibition of phosphatidylinositol 3-kinase/protein kinase B signaling is not sufficient to account for indole-3-carbinol-induced apoptosis in some breast and prostate tumor cells. Clin Cancer Res 11:8521–8527PubMedCrossRef
30.
go back to reference Moiseeva EP, Fox LH, Howells LM et al (2006) Indole-3-carbinol-induced death in cancer cells involves EGFR downregulation and is exacerbated in a 3D environment. Apoptosis 11:799–812PubMedCrossRef Moiseeva EP, Fox LH, Howells LM et al (2006) Indole-3-carbinol-induced death in cancer cells involves EGFR downregulation and is exacerbated in a 3D environment. Apoptosis 11:799–812PubMedCrossRef
31.
go back to reference Moiseeva EP, Heukers R, Manson MM (2007) EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells. Carcinogenesis 28:435–445PubMedCrossRef Moiseeva EP, Heukers R, Manson MM (2007) EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells. Carcinogenesis 28:435–445PubMedCrossRef
32.
go back to reference Chinni SR, Li Y, Upadhyay S et al (2001) Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20:2927–2936PubMedCrossRef Chinni SR, Li Y, Upadhyay S et al (2001) Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20:2927–2936PubMedCrossRef
33.
go back to reference Takada Y, Andreeff M, Aggarwal BB (2005) Indole-3-carbinol suppresses NF-{kappa}B and I{kappa}B{alpha} kinase activation causing inhibition of expression of NF-{kappa}B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106:641–649PubMedCrossRef Takada Y, Andreeff M, Aggarwal BB (2005) Indole-3-carbinol suppresses NF-{kappa}B and I{kappa}B{alpha} kinase activation causing inhibition of expression of NF-{kappa}B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106:641–649PubMedCrossRef
34.
go back to reference Kucharczak J, Simmons MJ, Fan Y et al (2003) To be, or not to be: NF-kappaB is the answer—role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22:8961–8982PubMedCrossRef Kucharczak J, Simmons MJ, Fan Y et al (2003) To be, or not to be: NF-kappaB is the answer—role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22:8961–8982PubMedCrossRef
35.
go back to reference Hoffmann A, Natoli G, Ghosh G (2006) Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25:6706–6716PubMedCrossRef Hoffmann A, Natoli G, Ghosh G (2006) Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25:6706–6716PubMedCrossRef
36.
go back to reference Karin M, Cao Y, Greten FR et al (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310PubMedCrossRef Karin M, Cao Y, Greten FR et al (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310PubMedCrossRef
37.
go back to reference Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938–6947PubMedCrossRef Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938–6947PubMedCrossRef
38.
go back to reference Romieu-Mourez R, Kim DW, Shin SM et al (2003) Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 23:5738–5754PubMedCrossRef Romieu-Mourez R, Kim DW, Shin SM et al (2003) Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol 23:5738–5754PubMedCrossRef
39.
go back to reference Varela LM, Stangle-Castor NC, Shoemaker SF et al (2001) TNFalpha induces NFkappaB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. J Cell Physiol 188:120–131PubMedCrossRef Varela LM, Stangle-Castor NC, Shoemaker SF et al (2001) TNFalpha induces NFkappaB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. J Cell Physiol 188:120–131PubMedCrossRef
40.
go back to reference Landesman-Bollag E, Song DH, Romieu-Mourez R et al (2001) Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Mol Cell Biochem 227:153–165PubMedCrossRef Landesman-Bollag E, Song DH, Romieu-Mourez R et al (2001) Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Mol Cell Biochem 227:153–165PubMedCrossRef
41.
go back to reference Bhat-Nakshatri P, Newton TR, Goulet R Jr et al (1998) NF-kappaB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha. Proc Natl Acad Sci USA 95:6971–6976PubMedCrossRef Bhat-Nakshatri P, Newton TR, Goulet R Jr et al (1998) NF-kappaB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha. Proc Natl Acad Sci USA 95:6971–6976PubMedCrossRef
42.
go back to reference Pederson L, Winding B, Foged NT et al (1999) Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res 59:5849–5855PubMed Pederson L, Winding B, Foged NT et al (1999) Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res 59:5849–5855PubMed
43.
go back to reference Bhat-Nakshatri P, Sweeney CJ, Nakshatri H (2002) Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells. Oncogene 21:2066–2078PubMedCrossRef Bhat-Nakshatri P, Sweeney CJ, Nakshatri H (2002) Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells. Oncogene 21:2066–2078PubMedCrossRef
44.
go back to reference Biswas DK, Cruz AP, Gansberger E et al (2000) Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci USA 97:8542–8547PubMedCrossRef Biswas DK, Cruz AP, Gansberger E et al (2000) Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci USA 97:8542–8547PubMedCrossRef
45.
go back to reference Madrid LV, Wang CY, Guttridge DC et al (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20:1626–1638PubMedCrossRef Madrid LV, Wang CY, Guttridge DC et al (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20:1626–1638PubMedCrossRef
46.
go back to reference Ali S, Kaur J, Patel KD (2000) Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation. Am J Pathol 157:313–321PubMed Ali S, Kaur J, Patel KD (2000) Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation. Am J Pathol 157:313–321PubMed
47.
go back to reference Newton TR, Patel NM, Bhat-Nakshatri P et al (1999) Negative regulation of transactivation function but not DNA binding of NF-kappaB and AP-1 by IkappaBbeta1 in breast cancer cells. J Biol Chem 274:18827–18835PubMedCrossRef Newton TR, Patel NM, Bhat-Nakshatri P et al (1999) Negative regulation of transactivation function but not DNA binding of NF-kappaB and AP-1 by IkappaBbeta1 in breast cancer cells. J Biol Chem 274:18827–18835PubMedCrossRef
48.
go back to reference Mendez O, Martin B, Sanz R et al (2006) Underexpression of transcriptional regulators is common in metastatic breast cancer cells overexpressing Bcl-xL. Carcinogenesis 27:1169–1179PubMedCrossRef Mendez O, Martin B, Sanz R et al (2006) Underexpression of transcriptional regulators is common in metastatic breast cancer cells overexpressing Bcl-xL. Carcinogenesis 27:1169–1179PubMedCrossRef
49.
go back to reference Espana L, Fernandez Y, Rubio N et al (2004) Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res Treat 87:33–44PubMedCrossRef Espana L, Fernandez Y, Rubio N et al (2004) Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res Treat 87:33–44PubMedCrossRef
50.
go back to reference Neve RM, Chin K, Fridlyand J et al (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515–527PubMedCrossRef Neve RM, Chin K, Fridlyand J et al (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515–527PubMedCrossRef
51.
go back to reference Rice NR, MacKichan ML, Israel A (1992) The precursor of NF-kappa B p50 has I kappa B-like functions. Cell 71:243–253PubMedCrossRef Rice NR, MacKichan ML, Israel A (1992) The precursor of NF-kappa B p50 has I kappa B-like functions. Cell 71:243–253PubMedCrossRef
52.
go back to reference Patel NM, Nozaki S, Shortle NH et al (2000) Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene 19:4159–4169PubMedCrossRef Patel NM, Nozaki S, Shortle NH et al (2000) Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene 19:4159–4169PubMedCrossRef
53.
go back to reference Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392–401PubMedCrossRef Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392–401PubMedCrossRef
54.
go back to reference Glasgow JN, Qiu J, Rassin D et al (2001) Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain. Neurochem Res 26:647–659PubMedCrossRef Glasgow JN, Qiu J, Rassin D et al (2001) Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain. Neurochem Res 26:647–659PubMedCrossRef
55.
go back to reference Gordon LA, Mulligan KT, Maxwell-Jones H et al (2003) Breast cell invasive potential relates to the myoepithelial phenotype. Int J Cancer 106:8–16PubMedCrossRef Gordon LA, Mulligan KT, Maxwell-Jones H et al (2003) Breast cell invasive potential relates to the myoepithelial phenotype. Int J Cancer 106:8–16PubMedCrossRef
56.
go back to reference Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396:77–80PubMedCrossRef Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396:77–80PubMedCrossRef
57.
go back to reference Das R, Mahabeleshwar GH, Kundu GC (2003) Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem 278:28593–28606PubMedCrossRef Das R, Mahabeleshwar GH, Kundu GC (2003) Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem 278:28593–28606PubMedCrossRef
58.
go back to reference Sliva D, Rizzo MT, English D (2002) Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 277:3150–3157PubMedCrossRef Sliva D, Rizzo MT, English D (2002) Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 277:3150–3157PubMedCrossRef
59.
go back to reference Huang WC, Chen JJ, Chen CC (2003) c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. J Biol Chem 278:9944–9952PubMedCrossRef Huang WC, Chen JJ, Chen CC (2003) c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. J Biol Chem 278:9944–9952PubMedCrossRef
60.
go back to reference Huang WC, Chen JJ, Inoue H et al (2003) Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression. J Immunol 170:4767–4775PubMed Huang WC, Chen JJ, Inoue H et al (2003) Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression. J Immunol 170:4767–4775PubMed
61.
go back to reference Jalal DI, Kone BC (2006) Src activation of NF-kappaB augments IL-1beta-induced nitric oxide production in mesangial cells. J Am Soc Nephrol 17:99–106PubMedCrossRef Jalal DI, Kone BC (2006) Src activation of NF-kappaB augments IL-1beta-induced nitric oxide production in mesangial cells. J Am Soc Nephrol 17:99–106PubMedCrossRef
62.
go back to reference Qing G, Qu Z, Xiao G (2005) Regulation of NF-kappa B2 p100 processing by its cis-acting domain. J Biol Chem 280:18–27PubMed Qing G, Qu Z, Xiao G (2005) Regulation of NF-kappa B2 p100 processing by its cis-acting domain. J Biol Chem 280:18–27PubMed
63.
go back to reference Saccani S, Pantano S, Natoli G (2003) Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11:1563–1574PubMedCrossRef Saccani S, Pantano S, Natoli G (2003) Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11:1563–1574PubMedCrossRef
64.
go back to reference Moorthy AK, Ghosh G (2003) p105.Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B. J Biol Chem 278:556–566PubMedCrossRef Moorthy AK, Ghosh G (2003) p105.Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B. J Biol Chem 278:556–566PubMedCrossRef
65.
go back to reference Lombaerts M, van Wezel T, Philippo K et al (2006) E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 94:661–671PubMed Lombaerts M, van Wezel T, Philippo K et al (2006) E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 94:661–671PubMed
66.
go back to reference Funakoshi-Tago M, Tago K, Andoh K et al (2005) Functional role of c-Src in IL-1-induced NF-kappa B activation: c-Src is a component of the IKK complex. J Biochem (Tokyo) 137:189–197 Funakoshi-Tago M, Tago K, Andoh K et al (2005) Functional role of c-Src in IL-1-induced NF-kappa B activation: c-Src is a component of the IKK complex. J Biochem (Tokyo) 137:189–197
67.
go back to reference Abu-Amer Y, Ross FP, McHugh KP et al (1998) Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha. J Biol Chem 273:29417–29423PubMedCrossRef Abu-Amer Y, Ross FP, McHugh KP et al (1998) Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha. J Biol Chem 273:29417–29423PubMedCrossRef
68.
go back to reference Fan C, Li Q, Zhang Y et al (2004) IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J Clin Invest 113:746–755PubMed Fan C, Li Q, Zhang Y et al (2004) IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J Clin Invest 113:746–755PubMed
69.
go back to reference Habib AA, Chatterjee S, Park SK et al (2001) The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome. J Biol Chem 276:8865–8874PubMedCrossRef Habib AA, Chatterjee S, Park SK et al (2001) The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome. J Biol Chem 276:8865–8874PubMedCrossRef
70.
go back to reference Kapoor GS, Zhan Y, Johnson GR et al (2004) Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells. Mol Cell Biol 24:823–836PubMedCrossRef Kapoor GS, Zhan Y, Johnson GR et al (2004) Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells. Mol Cell Biol 24:823–836PubMedCrossRef
71.
go back to reference Beraud C, Henzel WJ, Baeuerle PA (1999) Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad Sci USA 96:429–434PubMedCrossRef Beraud C, Henzel WJ, Baeuerle PA (1999) Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad Sci USA 96:429–434PubMedCrossRef
72.
go back to reference Davies SP, Reddy H, Caivano M et al (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95–105PubMedCrossRef Davies SP, Reddy H, Caivano M et al (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95–105PubMedCrossRef
73.
go back to reference Monks NR, Pardee AB (2006) Targeting the NF-kappaB pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs. J Cell Biochem 98:221–233PubMedCrossRef Monks NR, Pardee AB (2006) Targeting the NF-kappaB pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs. J Cell Biochem 98:221–233PubMedCrossRef
74.
go back to reference Chang HY, Yang X (2000) Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev 64:821–846PubMedCrossRef Chang HY, Yang X (2000) Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev 64:821–846PubMedCrossRef
75.
go back to reference Rahman KM, Li Y, Sarkar FH (2004) Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 48:84–94PubMedCrossRef Rahman KM, Li Y, Sarkar FH (2004) Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 48:84–94PubMedCrossRef
76.
go back to reference Kloth MT, Laughlin KK, Biscardi JS et al (2003) STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J Biol Chem 278:1671–1679PubMedCrossRef Kloth MT, Laughlin KK, Biscardi JS et al (2003) STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J Biol Chem 278:1671–1679PubMedCrossRef
Metadata
Title
Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death
Authors
Elena P. Moiseeva
Raimond Heukers
Publication date
01-06-2008
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2008
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9669-6

Other articles of this Issue 3/2008

Breast Cancer Research and Treatment 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine